Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Amphotericin B Colloidal Dispersion

Known as: AMPHOTERICIN B CHOLESTERYL SULFATE, Amphotericin B Colloidal Dispersion [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

28 relations
AIDS-Related Opportunistic InfectionsAmphotericin 100mg powder for infusion solution vialAmphotericin B Cholesterol DispersionAntifungal Agents
Expand

Broader (3)

Amphotericin BCholesterol Estersamphotericin B liposomal

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
Because of the increasing prevalence and changing microbiological spectrum of invasive fungal infections, some form of… Expand
  • table 1
  • table 2
Review
2001
Review
2001
Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion
Abstract The aim of this study was to review the characteristics and outcome of 21 patients with invasive mucormycosis treated… Expand
  • table 2
Review
2001
Review
2001
Amphotericin B colloidal dispersion: an improved antifungal therapy.
  • L. Guo
  • Advanced drug delivery reviews
  • 2001
    • Corpus ID: 31901839
Amphotericin B colloidal dispersion (ABCD) is a near 1:1 discoidal complex of amphotericin B (AMB) and sodium cholesteryl sulfate… Expand
Review
1999
Review
1999
Safety and Efficacy of Amphotericin B Colloidal Dispersion
The efficacy and safety of Amphotericin B Colloidal Dispersion (ABCD) have been investigated on 572 patients in five Phase I/II… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
1998
Highly Cited
1998
Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
We conducted a prospective, randomized, double-blind study comparing amphotericin B colloidal dispersion (ABCD) with amphotericin… Expand
  • table 1
  • table 2
  • table 3
Highly Cited
1998
Highly Cited
1998
Amphotericin B Colloidal Dispersion Combined with Flucytosine with or without Fluconazole for Treatment of Murine Cryptococcal Meningitis
ABSTRACT Studies with animals and in vitro studies have demonstrated that flucytosine plus amphotericin B or fluconazole has… Expand
Highly Cited
1997
Highly Cited
1997
Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.
To assess the efficacy and safety of amphotericin B colloidal dispersion (ABCD), 82 patients with proven or probable… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Highly Cited
1995
Highly Cited
1995
The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses.
Amphotericin B colloidal dispersion (ABCD), a novel formulation of amphotericin B and cholesteryl sulfate in a 1:1 ratio, was… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Highly Cited
1994
Highly Cited
1994
Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis
We investigated the safety and efficacy of amphotericin B colloidal dispersion (ABCD) for the treatment of invasive pulmonary… Expand
Review
1992
Review
1992
Liposomal and Lipid Formulations of Amphotericin B
SummaryAmphotericin B remains a very important drug for the treatment of fungal infections despite its toxicity. Encapsulation of… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE